000 | 01973 a2200553 4500 | ||
---|---|---|---|
005 | 20250515233009.0 | ||
264 | 0 | _c20101001 | |
008 | 201010s 0 0 eng d | ||
022 | _a1096-8652 | ||
024 | 7 |
_a10.1002/ajh.21791 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrara, Felicetto | |
245 | 0 | 0 |
_aDay 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results. _h[electronic resource] |
260 |
_bAmerican journal of hematology _cSep 2010 |
||
300 |
_a687-90 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aBlast Crisis _xgenetics |
650 | 0 | 4 |
_aBone Marrow _xpathology |
650 | 0 | 4 | _aChromosome Aberrations |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aIzzo, Tiziana | |
700 | 1 | _aCriscuolo, Clelia | |
700 | 1 | _aRiccardi, Cira | |
700 | 1 | _aCelentano, Maria | |
700 | 1 | _aMele, Giuseppina | |
773 | 0 |
_tAmerican journal of hematology _gvol. 85 _gno. 9 _gp. 687-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.21791 _zAvailable from publisher's website |
999 |
_c19993447 _d19993447 |